lost in pennyland
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ladies and Gentlemen, we're sitting on a goldmine here.
I just caught the end of an interview on NPR with Dr. Alan Lichter. It was a terrific interview which you can listen to at NPR.org.
The interviewer asked what major breakthrough against cancer he saw on the horizon.
To paraphrase the doctor, "diagnostic screening tests that detect proteins in the blood that are linked to cancer. The most treatable cancer is the cancer we don't get."
My take:
The doctor at the forefront of the this research is Dr. David Sidransky, who in 1996 famously tested tissues collected from former vice president Hubert Humphrey to prove that his test for bladder cancer was effective in detecting the disease.
Not really even a loan if you read it thoroughly. They're giving Aero $1.5 mil in cash as part of the deal. In return FCCN brass gets shares in Aero.
We are officially Aero-Exhaust shareholders! Gotta love that. I can't wait for Daytona baby!!!!
Bids stacking now. Can we reach .50 today? Still 7 trades to 1.00.
What's ridiculous is that this was rated a strong buy by many analysts prior to the tank. Anyone who believed the analysts on this one got creamed.
check that, down to 7 now.
8 trades to reach a dollar.
Thanks planner, great job.
Well you know, religion is a multi-billion dollar industry...
.15X.25 now there's a spread you don't see every day.
What's that noise I hear? Is that .50 coming?
Hint: The new company won't neccesarily have anything to do with the letters CSBR.
As long as he holds the majority of the shares he has all of the bargaining power, doesn't he? What do you think is the reason that they bought 28%?
He wants to be a part of the new company, whatever it morphs into. The docs are friends of his so I imagine they'll work together if/when they go public.
He owned the majority of the shares, so initially they had to negotiate with Mr. Martel if they wanted a piece of his shell. They could buy up the float now and take the majority position, but I doubt that is what they'll do.
I was reading up on Dr. Sidransky last night. There's a guy that's worthy of this shell. The word prolific is an understatement. He followed in his father's footsteps, who wrote books on biochemistry. His sister is also a doctor.
He's currently working on a diagnostic test for lung cancer, one of the most common types of cancer.
Good news for us, this shining star of oncology just bought millions of shares of stock in our pristine shell. And apparently he's already formed a number of private biotechs, although I couldn't find any of them last night.
I'm sure they'll change the name once the new company is in place.
When you wade through one bloated penny stock after another, a float this low is mesmerizing.
Ed, have you ever heard of owners of the shell company losing their investments in a reverse merger?
I'm in another reverse merger in the works right now (FCCN). There have been thousands of messages posted there over the last month. There have been plenty of posts that have tried to put a negative spin on the merger.
I've yet to read the post that claimed that it was possible that the stockholders prior to the merger might lose their shares.
I think we have a suberbowl finalist. I don't think the bears or the Seahawks can handle Reggie and Deuce.
I've been reading a lot on Reverse Mergers on I-hub and I have never heard of that happening. A heavy reverse split or dilution probably is the biggest hit the shell investors take. I don't expect that will be an issue here with Mr. Martel. It's too small to reverse split and we know his history on dilution.
I'd like to hear MWM and edfrankie's response to your question though. It sounds like they have a lot of experience in this area.
A lot of possible life saving products in those three studies. They're continuing to develop tests for early detection of multiple cancers.
In the last study they're trying to develop a drug that would reduce the toxicity of a currently approved cancer drug. That would allow people to continue to take the drug until the cancer is completely destroyed.
From buyins.net
Champions Sports Inc (OTCBB: CSBR) does not have significant operations. The company intends to serve as a vehicle to effect a new business or a business combination with a private entity.Previously, it operated a sports bar restaurant in San Antonio...
So we now know that Dr. Sidransky has started a number of private companies, that he and Dr. Hidalgo just purchased 28% of the company, and that CSBR intends to serve as a vehicle for a new business or private entity.
They may intend to bring one of their own companies public, or they see the potential in bringing one of the companies they work with (through one of Dr. Sidransky's board memberships or through Dr. Hidalgo's lead investigative work) public.
If they did buy in out of concern for Mr. Martel's financial hardship, what better way to reward their friend who resisted the temptation of defrauding investors with hype and selling shares, than to fill his clean shell with a new juggernaut biotech company?
It would be worth many time the $30,000 they paid for the shares.
Yes I think this is a very valuable shell at this point based on the three primary shareholders who own 2/3 of the company. The credentials of Dr. Sidransky and Dr. Hidalgo represent potential worth thousands of times 13 million.
And the way Mr. Martel has managed his public company should give investors confidence in the upward mobility of the share price until the shell is filled.
Since I wrote that, we've been filled in even more. It's been confirmed that Dr. Sidransky is interested in the business side of biotechs. Not only has he served on numerous boards, he's already formed numerous private companies.
Hmmm...
Thanks fringe, this has been a fun one to ride in so far.
Now if they can put Sidransky's and Hidalgo's work into it, we could have a nice start-up biotech at about $10.00 a share. :)
Yeah, he needs to go on a three game tear.
I'm a bears fan. Perhaps we will see you at soldiers field in a week... I don't know if the bears can handle Reggie Bush at this point. I'm afraid my boy Urlacher, as awesome as he is, may be a bit of a playoff choker.
Hopefully if they get a win under their belts against the struggling Seahawks they can regain that '85 swagger they had earlier in the season. I'll be happy if they can pull off what should be an easy home win.
I agree, the vehicle is a thing of beauty. Imagine a promising biotech or another AeroExhaust driving it.
Hey spark, first I want to commend you for how you handled running the board the other day. Or was that Matt? Whoever was running the FCCN board Tuesday(?) morning did one hell of a job.
If Jim had a plan, he wasn't going to share it with me. I took his anti-hype and running the business correctly comments to mean that he wasn't going to tell me even if there was something about to happen.
He told me he was looking for a new opportunity. We know that Dr. Sidransky has a boat-load of patents and a desire to create the most potent cancer screen possible. I have a hard time believing that this is just a couple of buddies passively buying millions of shares in an empty shell. They must have something in mind, don't you think?
Thanks tweet for giving me my first mark. I think this one might be worth the wait.
I just spoke with Jim Martel. It was a very reassuring conversation. He confirmed that there are about 27.3 mil shares outstanding. He confirmed the 50 mil shares authorized. He said that Drs. Sidranksy and Hidalgo are friends of his. He said that yes the three do hold a majority interest in the company with over 2/3 of the total shares.
What I was particularly amazed by was shell. This is a pristine shell. We're going to be hard-pressed to find a company worthy of this shell. He's owned this public company since 1985. The shares were reverse split in 1990. So for the last 17 years he's kept the share count below 30 million. Until recently it was below 20 million.
I congratulated him on the way he ran his company. He was very proud that he didn't have any of the baggage that most penny stocks accrue. He said he was all about running the business, not running a PR machine and selling shares. This is a rare quality in penny land. I told him that this stock was positioned for a great run with the right company. He said he didn't consider his company a shell, more like a vehicle to begin a good company with.
He said his involvement with the diabetes association was due to his daughter's illness with the disease. He downplayed the implications of the doctors' investments. He said when something develops he'll make an announcement.
I think this company is worth .50 just based on the resumes and integrity of the three primary shareholders, the lack of legal and financial issues, and the share structure.
It's quite a precious combo in penny land.
My dream for this one from the current information we have is that they become a diagnostic testing company. It's been five years since that article on Dr. Sidransky's work(dated 2001 I think). Since that time they have perfected a test that can screen for multiple cancers at a high confidence rate.
This test becomes a routine screen for everyone over the age of 30 or 40 worldwide.
.20 by the end of day?
Yeah I'm fine with that. Once again this PR offers plenty of hints of what's coming.
Obviously the merger has been delayed until next week and they're trying to tide us over with a little preview of things to come.
They were probably planning on issuing this PR shortly after the merger. It probably would have been more effective in that order. Then again it probably won't really matter once we get merger and financial news.
That's what I was thinking. A couple more players with their own set of credentials will be coming on board soon. Perhaps people with extensive experience in the business side of biotechs.
CSBR is a reverse merger in the works - two prominent oncology docs just bought millions of shares. It looks like they're going to use it as a shell to begin a biotech company. One of the docs formerly of Imclone, now Johns Hopkins has about 100 patents by himself.
The float is only 7 million! It's currently at .19.
Goodness, he's a one man patent machine. I'm liking my .15 cent shares more all the time.
Hey sorry I didn't give you a full response earlier. I had to get to work.
I'm basing my judgement upon my conversation with Andrew Beyer, who was very forthcomming in laying out the position of the company. And I read the descriptions about Peacock, the other board members and the new board members.
Peacock already has a history of turning companies around. And everything they've done with this merger has reinforced my confidence in this group.
I've invested heavily in this company, and I believe it's (to borrow your moniker) the real deal.
This management team is rock solid. They'll deliver on time.
Imagine the gaps this chart is going to create. If you're looking for gaps you aint seen nothin' yet. This is going to be sudden and swift.
Thanks Dyno, GO JEREMY!
So Jeremy Mayfield is driving the AERO car now?
If he's right, I'm calling in sick. But even if he's not, I think we're going to resume the rocket ride today!
SCOTTY, IGNITE THE THRUSTERS!